ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

DeVita Considers Laetrile Tests

June 3, 1977

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992